All lobbying filings
Miller Strategies, LLC
Miller Strategies, LLC filed a Q2 report for Amgen, Inc. on July 21, 2025, reporting $60,000 in lobbying income.
Lobbying for Amgen, Inc. · biopharmaceutical company
Filing · LD-2 quarterly report
Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 21, 2025
Income
$60,000
What the client paid this registrant for the period.
Client based in
District of Columbia
Lobbying activity
3
Issues related to drug pricing, biosimilars, Medicare Part D and Medicare Part B; H.R. 3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021
Issues related to visas
Healthcare policy issues as they relate to the pharmaceutical industry including drug pricing and biosimilars
Bills named in this filing
1